David M Lubaroff
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer (NCT00583024) | David M Lubaroff | 2007-12-01 |
| Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (NCT00583752) | David M Lubaroff | 2007-12-01 |
Track David M Lubaroff automatically
Every clearance here is in the API, with alerts when new ones post.